Efficacy of interferon β1a (Cinnovex) in relapsing-remitting multiple sclerosis patients
| Author | Naser Sharafaddinzadeh | en |
| Author | Nastaran Majdinasab | en |
| Author | Masoud Ghiasian | en |
| Author | Armaghan Moravej-Aleali | en |
| Issued Date | 2011-05-31 | en |
| Abstract | Background : Multiple sclerosis is an inflammatory, chronic disease of the centre nervous system with demyelination in brain and spinal cord. Disability is evaluated by EDSS (Expanded Disability Scale Score). IFN β1a uses to prevent relapse rate and EDSS progression. The aim of this study was to evaluate efficacy of IFN β1a (Cinnovex) in relapsing- remitting multiple sclerosis patients. | en |
| DOI | https://doi.org/ | en |
| Keyword | Multiple sclerosis | en |
| Keyword | Cinnovex | en |
| Keyword | Avonex | en |
| Keyword | clinical sign | en |
| Publisher | Brieflands | en |
| Title | Efficacy of interferon β1a (Cinnovex) in relapsing-remitting multiple sclerosis patients | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ZJRMS-v13n2p3-en.pdf
- Size:
- 212.38 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF